Overall, there was a marginally significant trend for worse breast cancer specific survival for gBRCAm versus gBRCAwt [ 13 ].
← all excerpts
Prevalence, prognosis, and health care resource utilization in carriers of pathogenic germline variants in BRCA1/2 with incident early-stage breast cancer: a Finnish population-based study.
1
—
—